Skip to content
← Back to this collection

PUBLICATIONS · 25964250

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Aug 20
First author
Ben-Josef E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Aug 20;33(24):2588-90. doi: 10.1200/JCO.2015.61.6953.
    note
    Source null
    related pmid
    26195717
    relationship
    Comment in

Authors and identifiers

  1. name
    Ben-Josef E
    type
    Author
  2. name
    Guthrie KA
    type
    Author
  3. name
    El-Khoueiry AB
    type
    Author
  4. name
    Corless CL
    type
    Author
  5. name
    Zalupski MM
    type
    Author
  6. name
    Lowy AM
    type
    Author
  7. name
    Thomas CR Jr
    type
    Author
  8. name
    Alberts SR
    type
    Author
  9. name
    Dawson LA
    type
    Author
  10. name
    Micetich KC
    type
    Author
  11. name
    Thomas MB
    type
    Author
  12. name
    Siegel AB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ben-Josef E
    type
    Author
  2. name
    Guthrie KA
    type
    Author
  3. name
    El-Khoueiry AB
    type
    Author
  4. name
    Corless CL
    type
    Author
  5. name
    Zalupski MM
    type
    Author
  6. name
    Lowy AM
    type
    Author
  7. name
    Thomas CR Jr
    type
    Author
  8. name
    Alberts SR
    type
    Author
  9. name
    Dawson LA
    type
    Author
  10. name
    Micetich KC
    type
    Author
  11. name
    Thomas MB
    type
    Author
  12. name
    Siegel AB
    type
    Author
bibliography ids
  1. nci-bib-d538e5190dff3261eb08651b
book metadata
content sha256
1596d0652e9c64fcdaa96b46d6af6763aa9cae389bf62ba1a865944d317c83a8
document type
citation
dois
  1. 10.1200/JCO.2014.60.2219
electronic publication date
display
2015 May 11
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25964250
immutable id
pubmed:25964250@1596d0652e9c64fcdaa96b46d6af6763aa9cae389bf62ba1a865944d317c83a8
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
24
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2617-22
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Aug 20;33(24):2588-90. doi: 10.1200/JCO.2015.61.6953.
    note
    Source null
    related pmid
    26195717
    relationship
    Comment in
outcomes validated
false
pmid
25964250
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
48976ecd2367a4f01ac259eb3699555c6d0aad3c642d812d3ef036201c2d6fe0
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Aug 20
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25964250/
title
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Preserved source evidence · Not medical advice